142 related articles for article (PubMed ID: 36478760)
61. Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care.
Bidulka P; Fu EL; Leyrat C; Kalogirou F; McAllister KSL; Kingdon EJ; Mansfield KE; Iwagami M; Smeeth L; Clase CM; Bhaskaran K; van Diepen M; Carrero JJ; Nitsch D; Tomlinson LA
BMC Med; 2020 Jul; 18(1):195. PubMed ID: 32723383
[TBL] [Abstract][Full Text] [Related]
62. Racial/Ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction.
Lauffenburger JC; Robinson JG; Oramasionwu C; Fang G
Circulation; 2014 Feb; 129(7):754-63. PubMed ID: 24326988
[TBL] [Abstract][Full Text] [Related]
63. Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke.
Xian Y; Xu H; Matsouaka R; Laskowitz DT; Maisch L; Hannah D; Smith EE; Fonarow GC; Bhatt DL; Schwamm LH; Mac Grory B; Feng W; Fosbøl EL; Peterson ED; Johnson M
JAMA Netw Open; 2022 Jul; 5(7):e2224157. PubMed ID: 35900761
[TBL] [Abstract][Full Text] [Related]
64. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
[TBL] [Abstract][Full Text] [Related]
65. No gender differences in prognosis and preventive treatment in patients with AMI without significant stenoses.
Hansen KW; Hvelplund A; Abildstrøm SZ; Prescott E; Madsen M; Madsen JK; Jensen JS; Thuesen L; Thayssen P; Tilsted HH; Jørgensen E; Galatius S
Eur J Prev Cardiol; 2012 Aug; 19(4):746-54. PubMed ID: 21724682
[TBL] [Abstract][Full Text] [Related]
66. Adherence to agents acting on the renin-angiotensin system in secondary prevention of non-fatal myocardial infarction: a self-controlled case-series study.
Ortolani P; Di Bartolomeo S; Marino M; Vagnarelli F; Guastaroba P; Rapezzi C; De Palma R
Eur Heart J Cardiovasc Pharmacother; 2015 Oct; 1(4):254-9. PubMed ID: 27532449
[TBL] [Abstract][Full Text] [Related]
67. Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
Lindahl B; Baron T; Erlinge D; Hadziosmanovic N; Nordenskjöld A; Gard A; Jernberg T
Circulation; 2017 Apr; 135(16):1481-1489. PubMed ID: 28179398
[TBL] [Abstract][Full Text] [Related]
68. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey.
Yusuf S; Islam S; Chow CK; Rangarajan S; Dagenais G; Diaz R; Gupta R; Kelishadi R; Iqbal R; Avezum A; Kruger A; Kutty R; Lanas F; Lisheng L; Wei L; Lopez-Jaramillo P; Oguz A; Rahman O; Swidan H; Yusoff K; Zatonski W; Rosengren A; Teo KK;
Lancet; 2011 Oct; 378(9798):1231-43. PubMed ID: 21872920
[TBL] [Abstract][Full Text] [Related]
69. Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients.
Liu CL; Shau WY; Wu CS; Lai MS
J Hypertens; 2012 Nov; 30(11):2223-9. PubMed ID: 22929610
[TBL] [Abstract][Full Text] [Related]
70. Guideline-Based Medications for Older Adults Discharged after Percutaneous Coronary Intervention in a Suburban City of Japan: A Cohort Study Using Claims Data.
Shimada K; Hamada S; Sawano M; Yamamoto H; Yoshie S; Iijima K; Miyata H
Tohoku J Exp Med; 2020 Oct; 252(2):143-152. PubMed ID: 33028759
[TBL] [Abstract][Full Text] [Related]
71. Treatment with Multiple Therapeutic Classes of Medication Is Associated with Survival after Stroke.
Kilkenny MF; Olaiya MT; Dalli LL; Kim J; Andrew NE; Sanfilippo FM; Thrift AG; Nelson M; Pearce C; Sanders L; Dewey H; Clissold B; Grimley R; Cadilhac DA
Neuroepidemiology; 2022; 56(1):66-74. PubMed ID: 34758474
[TBL] [Abstract][Full Text] [Related]
72. Comparative effectiveness of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers in patients with type 2 diabetes and retinopathy.
Shih CJ; Chen HT; Kuo SC; Li SY; Lai PH; Chen SC; Ou SM; Chen YT
CMAJ; 2016 May; 188(8):E148-E157. PubMed ID: 27001739
[TBL] [Abstract][Full Text] [Related]
73. Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
Gilstrap LG; Fonarow GC; Desai AS; Liang L; Matsouaka R; DeVore AD; Smith EE; Heidenreich P; Hernandez AF; Yancy CW; Bhatt DL
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28189999
[TBL] [Abstract][Full Text] [Related]
74. Angiotensin receptor blockers (ARB) outperform angiotensin-converting enzyme (ACE) inhibitors on ischemic stroke prevention in patients with hypertension and diabetes - A real-world population study in Taiwan.
Pai PY; Muo CH; Sung FC; Ho HC; Lee YT
Int J Cardiol; 2016 Jul; 215():114-9. PubMed ID: 27111172
[TBL] [Abstract][Full Text] [Related]
75. Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase.
Kam W; Holmes DN; Hernandez AF; Saver JL; Fonarow GC; Smith EE; Bhatt DL; Schwamm LH; Reeves MJ; Matsouaka RA; Khan YM; Unverdorben M; Birmingham MC; Lyden PD; Asimos AW; Altschul D; Schoonover TL; Jumaa MA; Nomura JT; Suri MFK; Moore SA; Lafranchise EF; Olson D; Peterson ED; Xian Y
JAMA; 2022 Feb; 327(8):760-771. PubMed ID: 35143601
[TBL] [Abstract][Full Text] [Related]
76. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease.
Baker WL; Coleman CI; Kluger J; Reinhart KM; Talati R; Quercia R; Phung OJ; White CM
Ann Intern Med; 2009 Dec; 151(12):861-71. PubMed ID: 20008762
[TBL] [Abstract][Full Text] [Related]
77. Myopia and Childhood Migration: A Study of 607 862 Adolescents.
Peled A; Afek A; Twig G; Pras E; Rotenstreich Y; Sher I; Derazne E; Tzur D; Gordon B
Ophthalmology; 2020 Jun; 127(6):713-723. PubMed ID: 32005562
[TBL] [Abstract][Full Text] [Related]
78. Inequalities in medication adherence to statin treatment after stroke: A nationwide observational study.
Sjölander M; Eriksson M; Glader EL
Eur Stroke J; 2016 Jun; 1(2):101-107. PubMed ID: 31008271
[TBL] [Abstract][Full Text] [Related]
79. Few sex differences in the use of drugs for secondary prevention after stroke: a nationwide observational study.
Sjölander M; Eriksson M; Glader EL
Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):911-9. PubMed ID: 22069216
[TBL] [Abstract][Full Text] [Related]
80. Immigration, ethnicity, and avoidable mortality in Canada, 1991-2006.
Omariba DW
Ethn Health; 2015; 20(4):409-36. PubMed ID: 25567556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
